BR112012030652A2 - comprimidos que podem ser dispersos oralmente de eritritol e isomalte - Google Patents
comprimidos que podem ser dispersos oralmente de eritritol e isomalteInfo
- Publication number
- BR112012030652A2 BR112012030652A2 BR112012030652A BR112012030652A BR112012030652A2 BR 112012030652 A2 BR112012030652 A2 BR 112012030652A2 BR 112012030652 A BR112012030652 A BR 112012030652A BR 112012030652 A BR112012030652 A BR 112012030652A BR 112012030652 A2 BR112012030652 A2 BR 112012030652A2
- Authority
- BR
- Brazil
- Prior art keywords
- tablets
- seconds
- isomalt
- erythritol
- orally
- Prior art date
Links
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 title abstract 3
- 239000004386 Erythritol Substances 0.000 title abstract 3
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 title abstract 3
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 title abstract 3
- 235000019414 erythritol Nutrition 0.000 title abstract 3
- 229940009714 erythritol Drugs 0.000 title abstract 3
- 235000010439 isomalt Nutrition 0.000 title abstract 3
- 239000000905 isomalt Substances 0.000 title abstract 3
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 title abstract 3
- 239000003826 tablet Substances 0.000 abstract 4
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 230000006835 compression Effects 0.000 abstract 1
- 239000007919 dispersible tablet Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 238000005469 granulation Methods 0.000 abstract 1
- 230000003179 granulation Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000010998 test method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Medicinal Preparation (AREA)
- Fodder In General (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10005677 | 2010-06-01 | ||
| PCT/EP2011/002432 WO2011151018A2 (en) | 2010-06-01 | 2011-05-17 | Orodispersible tablets of erythritol and isomalt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012030652A2 true BR112012030652A2 (pt) | 2016-08-16 |
Family
ID=42735711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012030652A BR112012030652A2 (pt) | 2010-06-01 | 2011-05-17 | comprimidos que podem ser dispersos oralmente de eritritol e isomalte |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130072578A1 (https=) |
| EP (1) | EP2575755A2 (https=) |
| JP (1) | JP5902677B2 (https=) |
| KR (1) | KR20130086159A (https=) |
| CN (1) | CN102905691A (https=) |
| BR (1) | BR112012030652A2 (https=) |
| CA (1) | CA2800266A1 (https=) |
| MX (1) | MX2012013759A (https=) |
| WO (1) | WO2011151018A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6012373B2 (ja) * | 2012-09-28 | 2016-10-25 | 杏林製薬株式会社 | 口腔内崩壊錠 |
| JP7486258B2 (ja) * | 2019-12-26 | 2024-05-17 | 物産フードサイエンス株式会社 | 口腔内崩壊錠用顆粒、その製造方法および口腔内崩壊錠 |
| CN112137097A (zh) * | 2020-10-10 | 2020-12-29 | 广东青云山药业有限公司 | 一种口腔速溶颗粒及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT922464E (pt) * | 1996-07-12 | 2005-07-29 | Daiichi Seiyaku Co | Materiais moldados por compressao rapidamente desintegraveis e processo para a sua producao |
| JPH10182436A (ja) * | 1996-10-31 | 1998-07-07 | Takeda Chem Ind Ltd | 固形医薬製剤 |
| DE602005013232D1 (de) * | 2004-07-01 | 2009-04-23 | Lek Pharmaceuticals | Schnell zerfallende im mund dispergierbare zusammensetzung mit nicht-filamentösen mitverarbeiteten polyol-teilchen und verkieselter mikrokristalliner cellulose |
| JP2008037853A (ja) * | 2006-08-01 | 2008-02-21 | Higuchi Shokai:Kk | イソマルトを含有する速崩壊性医薬品固形製剤 |
| CN103691530A (zh) | 2007-07-27 | 2014-04-02 | 卡吉尔公司 | 多元醇的微粉化 |
| EP2153822A1 (en) * | 2008-08-13 | 2010-02-17 | Lek Pharmaceuticals D.D. | Granulation of active pharmaceutical ingredients |
| FR2933299B1 (fr) | 2008-07-04 | 2012-02-03 | Roquette Freres | Mannitol orodispersible |
| ES2377869T3 (es) | 2008-09-04 | 2012-04-02 | Cargill, Incorporated | Fabricación de comprimidos de eritritol |
| NZ592528A (en) | 2008-11-17 | 2013-05-31 | Nycomed Pharma As | Improved dissolution stability of calcium carbonate tablets |
-
2011
- 2011-05-17 WO PCT/EP2011/002432 patent/WO2011151018A2/en not_active Ceased
- 2011-05-17 US US13/701,051 patent/US20130072578A1/en not_active Abandoned
- 2011-05-17 MX MX2012013759A patent/MX2012013759A/es not_active Application Discontinuation
- 2011-05-17 KR KR1020127034435A patent/KR20130086159A/ko not_active Ceased
- 2011-05-17 EP EP11721714.1A patent/EP2575755A2/en not_active Withdrawn
- 2011-05-17 CA CA2800266A patent/CA2800266A1/en not_active Abandoned
- 2011-05-17 JP JP2013512780A patent/JP5902677B2/ja not_active Expired - Fee Related
- 2011-05-17 CN CN2011800270378A patent/CN102905691A/zh active Pending
- 2011-05-17 BR BR112012030652A patent/BR112012030652A2/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2011151018A3 (en) | 2012-05-31 |
| MX2012013759A (es) | 2013-01-24 |
| CN102905691A (zh) | 2013-01-30 |
| JP5902677B2 (ja) | 2016-04-13 |
| JP2013530163A (ja) | 2013-07-25 |
| EP2575755A2 (en) | 2013-04-10 |
| US20130072578A1 (en) | 2013-03-21 |
| CA2800266A1 (en) | 2011-12-08 |
| KR20130086159A (ko) | 2013-07-31 |
| WO2011151018A2 (en) | 2011-12-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Late et al. | Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets | |
| Saif et al. | Formulation and evaluation of trimetazidine hydrochloride and clopidogrel bisulphate multi-unit solid dosage forms | |
| Rane et al. | Formulation and evaluation of fast dissolving tablet of albendazole | |
| BR112014018378A8 (pt) | Processo contínuo para a preparação de um comprimido compreendendo ácido 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol5-il) ciclopropanocarboxamido)-3-metilpiridin-2-il)benzoico | |
| Pathan et al. | Formulation design and optimization of novel mouth dissolving tablets for venlafaxine hydrochloride using sublimation technique | |
| BRPI0606332A2 (pt) | composição farmacêutica de bendamustina, preparação liofilizada, forma de dosagem farmacêutica, método para obter aprovação oficial para um produto de bendamustina, processo para fabricar uma preparação liofilizada de bendamustina, solução ou dispersão de pré-liofilização de bendamustina, pó liofilizado, método para preparar uma preparação liofilizada de bendamustina, formulação para liofilização, e, uso de uma solução farmaceuticamente aceitável | |
| BRPI0707044B8 (pt) | comprimido matricial insolúvel em água e processo de fabricação de comprimidos matriciais | |
| AR065096A1 (es) | Preparacion solida | |
| FI3182975T3 (fi) | Rukaparibin suuren annosvahvuuden tabletteja | |
| BR112014026292B1 (pt) | Comprimido oralmente desintegrável, e, processo para a produção de um comprimido oralmente desintegrável | |
| UA116334C2 (uk) | Тверді форми дозування бендамустину | |
| AR077546A1 (es) | Formulaciones de comprimidos de 3-cianoquinolina y usos de los mismos | |
| AR107391A1 (es) | Formulaciones / composiciones que comprenden un inhibidor de btk | |
| NO20082047L (no) | Sakte frigivende sammensetning, fremgangsmate for fremstilling derav og anvendelse av samme | |
| NO20090980L (no) | Kapecitabin pediatriske tabeletter | |
| ECSP11011559A (es) | Composiciones de dosis fija farmacéuticas sólidas que comprenden irbesartán y amlodipina, su preparación y su aplicación terapéutica | |
| AR100977A1 (es) | Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación | |
| JP2016108327A5 (https=) | ||
| AR061790A1 (es) | Composicion farmaceutica solida para la administracion oral, formulaciones de comprimidos de liberacion inmediata de un antagonista del receptor de trombina, y su uso en la manufactura de un medicamento | |
| BR112012030652A2 (pt) | comprimidos que podem ser dispersos oralmente de eritritol e isomalte | |
| Huynh et al. | Floating tablets incorporating curcumin solid dispersion as a potential pharmaceutical dosage form for stomach cancer treatment | |
| MY139086A (en) | Use of debranched starch in extrusion-spheronization pharmaceutical pellets | |
| BR112013022017A2 (pt) | formulação farmacêutica, comprimido, e, método para produzir uma formulação farmacêutica | |
| CN101632644B (zh) | 厄贝沙坦分散片及其制备方法 | |
| AR080895A1 (es) | Formulacion de comprimido de ezatiostat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] | ||
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |